THIS SHARE WILL BE WORTH 3.00 IN 2009

Looks like this is a push to increasing anti snake venom stock.
Can't do PTI any harm.

Fougera Marks Seventh Snakebite Season With CroFab Crotalidae Polyvalent Immune Fab (Ovine)
Urbanization and Climate Change Driving More Snakebites and New Strategies for Stocking Antivenom in 2007
MELVILLE, N.Y., March 13, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Fougera Inc. begins the 2007 snakebite season further ensuring adequate availability of CroFab(r) Crotalidae Polyvalent Immune Fab (Ovine), the only widely available antivenom for North American crotalid snakebite envenomations in the United States.

For Full article see link.....http://www.primenewswire.com/newsroom/news.html?d=115405

The anti venom product is small beer now.

We need FDA approval of the other stuff.......

SP continues to slide......... what did I say.

Transco,

Although now a small part of PTI, CroFab it is still a steady revenue earner.

As for SP continues to slide, I am sure you know as well as we do that it is totally down to the DOW, and is totally out of PTI's control.

stop bitching you two

Parthus,

Can't see where so called bitching comes into this.We both have differing opinions re PTI as regards, will it make you money or not.
Bitching to me is when things get personal, or/and comments with no back up whatsoever.
There are not many who post on this thread so we do take up a fairly large percentage of posts. I wish there were more to discus PTI with.
You are very welcome to put your views.

Greeknam,

Well said.

I respect your view and I really hope you are proved right.

Parthus whats your view anyway?

Transco

Fair point. I feel pti will be a rocky ride,but imho. the potential upside justifies the risk. Compared to my other holdings: CeNeS,IDData and Phytopharm[CEN,IDD,PYM] Protherics is a safer play. In my view the stock is undervalued,but that's for the market to decide. Regards to you both Parthus

Hi Parthus,

I think we all agree re the rocky ride.
Companies such as PTI never have a smooth ride, it's the way of the bio/drug type products.

I saw a paper the other day on a companies product trials, (a medical probe) it was 166 full AA pages long.
This was on a fairly simple device. It makes you wonder just how much written evidence is required from first submission to final acceptance of something more complex like a drug. No wonder it takes so long from concept to fruition.

Cheers Greek.

Looks like AXA have increased their holdings a bit, 318,221 added. Can't be bad

Greekman,

I will take any news as positive.

We are badly falling behind the broader market.

Then again even Glaxo got had a hard time today.

I dont see any major movement until the FDA report early next year.
I will sit on my hands till then.

Transco

Just read your post of 1yr ago trans. "Just keep your nerve". It's the same story for this year. I Feel patience will be rewarded handsomely. I'm also happy to hold for the medium term. Regards Parthus.

Parthus,

Nice one chum!!!

I should have remembered!!

Thanks for the thought!!

Things progressing in yet another drug. As with most such progress, this will move very slowly, but it shows PTI are always looking forward. Their R@D must be an envy of most similar market cap bio companies.

This new trial is in an area I'm not unfamiliar with. Xenova were running a similar trial on non-operable,re-occuring brain tumours of this nature. The cytotoxic agent was administered directly into the tumour site via a catheter. Unfortunately XEN was swallowed up by a parisitic buyout group. The encouraging point is pti's solid pipeline and stronger financials should carry them further.

I dont think there is a lot to this story chaps. Suspect that the company broker is looking for any good news they can find to prop up a failing share price.
Sorry to be negative but just my opinion!

Yeah it's gonna be a long drawn out story!

Blood Pressure Vaccine In Existence
Written by OJ Fagbire
Sunday, 13 May 2007

Protherics, a British drug company based in Cheshire, claims to have developed and tested a vaccine that will help people control their blood pressure levels. According to the firm, the vaccine has been extensively tested and should be released to the general public within the next half decade.

With high blood pressure being one of the fastest growing killers world wide, Protherics could have another long time winner on their books.
Again not one for the short term, but a possible winner in 4 to 5 years.

Exactly jam tomorrow - come on PTI lets see something concrete for once.
Who's the broker in charge - tell the story generate interest!!!!!!!!

Hi Transco,

The thing is with bio type companies, the jam is never now, due to the complexity and time scale for trials of such products.
Protherics are going from strength to strength at a nice pace.
It has never been a blue sky tomorrow share but an investment for the future.
This company are not one for putting out pure hype. Their releases contain good content.

Over the next 12 months there are sure to be updates re several of their products.

If you are looking at a bottom drawer share, this is the one.

A good day yesterday, at at the moment the sp is nicely higher, all on fairly low volume with buys not that much more than sells, which leads me to think a largish order is being filled.

A release soon perhaps of an institutional buy?

All IMHO of course.

Agree - this is old news recirculated...maybe not by the broker...perhaps the writer needed some spending money for the Bank Hol at the end of May (wash my mouth!)
This co has a Pipeline and Cash is coming in, so the current sp is "probably" about right....the "BP-drug" is starting trials (PhII) later this year'07 and we shall have to wait a while for the results....probably 2009

Another angle is that the Government is considering changing the Rules re NHS private medicine - at present if you want a non-approved treatment you have to go private (ie pay for everything)...there is a suggestion that folk would be prepared to pay for "the drug" if they had the treatment in their local NHS hospital....it might be a way to satisfy popular expectations of ever-more expensive treatments. That being so, this story might just turn the Minister's mind as the expected demand is likely to be great - if it does not have the usual (unfortunate) side-effect that Gentlemen would not prefer.
Therefore I suspect "this story" is all to do with the NHS ...and NOT Protherics, or their MM, trying to lift the sp.